title: What determines adherence to treatment in cardiovascular disease prevention? Protocol for a mixed methods preference study.
abstract: Background Significant gaps exist between guidelines-recommended therapies for cardiovascular disease prevention and current practice. Fixed-dose combination pills ('polypills') potentially improve adherence to therapy. This study is a preference study undertaken in conjunction with a clinical trial of a polypill and seeks to examine the underlying reasons for variations in treatment adherence to recommended therapy.  Methods/design A preference study comprising: (1) Discrete Choice Experiment for patients; and (2) qualitative study of patients and providers. Both components will be conducted on participants in the trial. A joint model combining the observed adherence in the clinical trial (revealed preference) and the Discrete Choice Experiment data (stated preference) will be estimated. Estimates will be made of the marginal effect (importance) of each attribute on overall choice, the extent to which respondents are prepared to trade-off one attribute for another and predicted values of the level of adherence given a fixed set of attributes, and contextual and socio-demographic characteristics. For the qualitative study, a thematic analysis will be used as a means of exploring in depth the preferences and ultimately provide important narratives on the experiences and perspectives of individuals with regard to adherence behaviour.  Ethics and dissemination Primary ethics approval was received from Sydney South West Area Health Service Human Research Ethics Committee (Royal Prince Alfred Hospital zone). In addition to usual scientific forums, the findings will be reported back to the communities involved in the studies through site-specific reports and oral presentations.
authors.affiliation: George Institute for Global Health, Camperdown, Australia.
authors.forename: Stephen
authors.initials: S
authors.lastname: Jan
authors.forename: Tim
authors.initials: T
authors.lastname: Usherwood
authors.forename: Jo Anne
authors.initials: JA
authors.lastname: Brien
authors.forename: David
authors.initials: D
authors.lastname: Peiris
authors.forename: John
authors.initials: J
authors.lastname: Rose
authors.forename: Noel
authors.initials: N
authors.lastname: Hayman
authors.forename: Kirsten
authors.initials: K
authors.lastname: Howard
authors.forename: Julie
authors.initials: J
authors.lastname: Redfern
authors.forename: Tracey
authors.initials: T
authors.lastname: Laba
authors.forename: Alan
authors.initials: A
authors.lastname: Cass
authors.forename: Anushka
authors.initials: A
authors.lastname: Patel
references.citation: Health Policy Plan. 2009 Mar;24(2):151-8
references.pmid: 19112071
references.citation: Ann Pharmacother. 2004 Sep;38(9):1363-8
references.pmid: 15238622
references.citation: BMJ. 2006 Feb 18;332(7538):413-6
references.pmid: 16484270
references.citation: BMJ. 2008 Sep 29;337:a1655
references.pmid: 18824488
references.citation: Heart. 2003 May;89 Suppl 2:ii6-9; discussion ii35-7
references.pmid: 12695426
references.citation: BMC Public Health. 2010 Aug 05;10:458
references.pmid: 20687931
references.citation: Hosp Pharm. 1995 Mar;30(3):201-3, 206-7
references.pmid: 10140764
references.citation: Health Econ. 2007 Nov;16(11):1185-204
references.pmid: 17304501
references.citation: Health Econ. 2004 Jun;13(6):563-73
references.pmid: 15185386
references.citation: Soc Sci Med. 2008 Feb;66(4):922-32
references.pmid: 18162273
references.citation: Diabetes Care. 1997 Oct;20(10):1512-7
references.pmid: 9314626
references.citation: Bull World Health Organ. 2004 Dec;82(12):935-9
references.pmid: 15654408
references.citation: Br J Clin Pharmacol. 2001 Jun;51(6):615-22
references.pmid: 11422022
references.citation: J Health Serv Res Policy. 2004 Jan;9(1):14-21
references.pmid: 15006235
references.citation: Clin Ther. 1996 Nov-Dec;18(6):1252-62
references.pmid: 9001841
references.citation: Med Care. 1997 Nov;35(11):1164-70
references.pmid: 9366895
references.citation: Health Expect. 2011 Mar;14(1):10-20
references.pmid: 20550589
references.citation: Appl Health Econ Health Policy. 2003;2(1):55-64
references.pmid: 14619274
references.citation: Circulation. 1997 Feb 18;95(4):1085-90
references.pmid: 9054774
references.citation: BMJ. 2003 Jun 28;326(7404):1419
references.pmid: 12829553